Clinical Trial Results

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

PHASE3INTERVENTIONAL Anniston, Alabama +4 more

RECRUITING

HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction

PHASE1, PHASE2INTERVENTIONAL Kansas City, Missouri +1 more

RECRUITING

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

PHASE3INTERVENTIONAL Anniston, Alabama +4 more

RECRUITING

Global Paradise System US Post Approval Study

N/AOBSERVATIONAL Long Beach, California +4 more

RECRUITING

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

N/AOBSERVATIONAL Birmingham, Alabama +4 more

RECRUITING

A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

PHASE3INTERVENTIONAL Los Angeles, California +4 more

RECRUITING

Pulmonary Hypertension Association Registry

N/AOBSERVATIONAL Phoenix, Arizona +4 more

RECRUITING

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

NAINTERVENTIONAL Scottsdale, Arizona +4 more

RECRUITING

Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

N/AOBSERVATIONAL Los Angeles, California +4 more

RECRUITING